Korean J Physiol Pharmacol.
1997 Feb;1(1):79-82.
Regulatory role of nitric oxide on atrial natriuretic peptide system in
normotensive and hypertensive rats
- Affiliations
-
- 1Department of Physiology, Chonnam University Medical School, Kwangiu
501-190 South Korea.
Abstract
-
The present study was aimed to explore an interaction between
endothelium-derived nitric oxide (NO) and atrial natriuretic peptide
(ANP) systems in normotensive and hypertensive states. Rats were made
two-kidney, one clip (2K1C) hypertensive and supplemented with either
N-G-nitro-L-arginine methyl ester (L-NAME, 5 mg/100 ml drinking water)
or L-arginine hydrochloride (400 mg/100 ml drinking water). One group
supplied with normal tap water served as control. Sham-clipped rats
were also divided into the L-NAME, L-arginine, and control groups. The
plasma levels and atrial contents of ANP were determined at day 28
following clipping the renal artery. In 2K1C rats, the plasma level of
ANP was higher and the atrial content was lower than in the
sham-clipped control. L-Arginine increased the atrial content of ANP in
association with a decreased plasma ANP, whereas L-NAME significantly
affected neither parameter. The increase of blood pressure in 2K1C rats
was not affected by L-arginine or L-NAME. In sham-clipped rats, the
plasma level of ANP was significantly increased by L-NAME along with an
increase in blood pressure. On the contrary, L-arginine did not affect
the blood pressure or plasma ANP. The atrial content of ANP was
significantly altered neither by L-arginine nor by L-NAME. These
results
suggest that NO plays a tonic inhibitory role on the ANP
release with concomitant increases of the atrial tissue content. In
addition, hypertension is suggested to modify the release and tissue
storage of ANP.